AnaptysBio, Inc. , a clinical stage biotechnology company, engages in developing therapeutic product candidates for inflammation and immuno-oncology indications.
Anaptysbio stock last closed at $64.78, down 0.05% from the previous day, and has increased 292.37% in one year. It has overperformed other stocks in the Biotechnology industry by 3.2 percentage points. Anaptysbio stock is currently +322.85% from its 52-week low of $15.32, and -2.92% from its 52-week high of $66.73.
As of Mar 16, 2026, there are 28.75M ANAB shares outstanding. The market value of ANAB is $1.86B. In the last 24 hours, 413,000 ANAB shares were traded.
How to Buy Anaptysbio Stock
Wondering how to invest in Anaptysbio stock? Here's how.
Decide where to buy Anaptysbio stock: You need to decide on a stock brokerage, but don't worry - we've tried dozens of online stock brokerages and apps to help you decide where to buy Anaptysbio stock.
Create a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
Deposit funds into your brokerage account: Select your payment method and add your information.
Analyze Anaptysbio stock: The Anaptysbio ticker symbol is ANAB. Is Anaptysbio stock a good investment? Should you buy shares of ANAB? How do ANAB's underlying business fundamentals look? Do top analysts think Anaptysbio is a good buy? Why has ANAB's stock price moved recently? (Hint: Our stock market research tools can help you figure out if ANAB is a good stock to buy).
Place your ANAB buy order: Decide if you will purchase ANAB shares at the current market price or use a limit order to purchase ANAB stock at a specific price.
Get the latest news on your ANAB position: Create a watchlist to get the latest news on your position in Anaptysbio stock.
Step 1: Decide where to buy Anaptysbio stock
You will need a brokerage account to access the NASDAQ market and buy ANAB shares.
A brokerage account is an investment account that allows you to buy and sell a number of investments, such as stocks, bonds, mutual funds, and ETFs.
Our favorite brokerage: eToro
We believe that eToro is the best online stock brokerage. Here's why:
Invest in stocks with zero commissions: Invest without paying trading commissions.
Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
Access to world markets: From Tech to Financial Services, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading exchanges.
Social investing: eToro boasts a community with more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of other investors.
Security: eToro is a regulated and licensed brokerage platform.
Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your purchase of stock by signing up for an account with eToro now. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Create a brokerage account
Now that you've selected the best brokerage, the next step is to fill out some personal information so you are able to invest in ANAB stock today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Analyze Anaptysbio stock
Once you have decided on the best place to buy Anaptysbio stock, it's absolutely critical to research their stock prior to buying, so you actually comprehend the risk as well as the upside.
Anaptysbio shares quick numbers
ANAB Price
$64.78
1w %
8.51%
1y %
292.37%
5y %
212.95%
P/E
-140.83x
P/B
50.05x
P/S
7.94x
PEG
N/A
Revenue
$234.60M
Earnings
-$13.23M
Fore. Rev. Growth
5.98%
Fore. Earn. Growth
N/A
Market Cap
$1.86B
Next Earnings
May 7, 2026
Next Dividend
N/A
ANAB Due Diligence Checks
WallStreetZen was created to help part-time investors perform more accurate fundamental analysis in less time.
There are more short-term assets than long-term liabilities on the ANAB balance sheet.
ANAB profit margin has gone up from -159.1% to -5.6% in the past year.
There are more short-term assets than short-term liabilities on the ANAB balance sheet.
Cons:
ANAB has a relatively high debt to equity ratio of 8.79.
Total ANAB debt is higher than 5 years ago, relative to shareholder equity.
ANAB earnings of -$13.07M is not sufficient to cover its interest payments.
ANAB's operating cash flow of $19.70M allows it to safely service it's debt of $290.64M.
Do Wall Street analysts think it's a good time to buy Anaptysbio stock
Out of 7 Wall Street analysts who research ANAB, the consensus analyst rating on Anaptysbio is a Strong Buy
It's important to note that analyst ratings are not stock recommendations, nor are they investment advice.
Most Recent ANAB Analyst Recommendations
Michael Yee, a top 15% analyst from UBS assumes ANAB with a strong buy rating and raises their ANAB price target from $20.00 to $70.00, on Jan 7, 2026.
UBS's Michael Yee assumed coverage on Anaptysbio (NASDAQ: ANAB) with a Strong Buy rating. The analyst also raised their price target by 250% from $20 to $70.
Assuming UBS' coverage on 22 SMID-cap biotech names, Yee pointed out that biotech's fundamentals are finally showing signs of improvement following a string of bad years.
The analyst is optimistic that the group is set to have a successful year in 2026 as investor confidence is expected to rebound.
Yee reported that their top picks among the group include
The analyst said those names have key upcoming catalysts, extensive pipelines, robust data, and de-risked best-in-class portfolios.
Yatin Suneja, a top 3% analyst from Guggenheim maintains ANAB with a strong buy rating and raises their ANAB price target from $90.00 to $100.00, on Nov 5, 2025.
Derek Archila, a top 3% analyst from Wells Fargo maintains ANAB with a strong buy rating and raises their ANAB price target from $51.00 to $81.00, on Nov 5, 2025.
Last year, ANAB revenue was $234.60M. Over the past five year, ANAB's revenue has grown by 25.62% per year. This was slower than the Biotechnology industry average of 29.11%.
No, Anaptysbio doesn't provide an income stream by paying out dividends.
ANAB Social Trading Data
One of the reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to see what other investors have to say.
Step 5: Place your ANAB buy order
You have two primary options:
Market order: A market order is an order to buy or sell a security at the best available price. Market orders are mostly the best for newer investors.
Limit order: A limit order enables you to buy or sell a stock at a specific price (or better). If you want to be certain you're buying or selling at a specific dollar amount limit, place a limit order.
Hit the Open button and your broker will execute your order.
If you need additional info about investing in stocks on eToro, click the how to video below:
How much does it cost to buy one Anaptysbio share?
As of Mar 16, 2026, it costs $64.78 to buy one share of Anaptysbio stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $10, you can buy 0.154 shares of ANAB.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.